| scholarly article | Q13442814 |
| P2093 | author name string | Ruth Gabizon | |
| Hanna Rosenmann | |||
| Kati Frid | |||
| Orli Binyamin | |||
| Yael Ungar | |||
| Keren Nitzan | |||
| P2860 | cites work | The Role of Autophagy, Mitophagy and Lysosomal Functions in Modulating Bioenergetics and Survival in the Context of Redox and Proteotoxic Damage: Implications for Neurodegenerative Diseases | Q26750137 |
| Fatal prion disease in a mouse model of genetic E200K Creutzfeldt-Jakob disease | Q27348644 | ||
| Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration | Q28140796 | ||
| Neurotoxicity induces cleavage of p35 to p25 by calpain | Q28145382 | ||
| Conjugated linolenic acid is slowly absorbed in rat intestine, but quickly converted to conjugated linoleic acid | Q28253158 | ||
| Cdk5 activity in the brain - multiple paths of regulation | Q33687591 | ||
| Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer's disease mouse model | Q33960315 | ||
| Calpain activation promotes BACE1 expression, amyloid precursor protein processing, and amyloid plaque formation in a transgenic mouse model of Alzheimer disease | Q34107259 | ||
| Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models | Q34418781 | ||
| Characterization of a Novel Mouse Model of Alzheimer's Disease--Amyloid Pathology and Unique β-Amyloid Oligomer Profile | Q35577702 | ||
| beta-Secretase, APP and Abeta in Alzheimer's disease. | Q36040315 | ||
| Understanding molecular mechanisms of proteolysis in Alzheimer's disease: progress toward therapeutic interventions | Q36212516 | ||
| Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant | Q36332494 | ||
| Involvement of calpain activation in neurodegenerative processes. | Q36588397 | ||
| Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease | Q36740290 | ||
| Prion diseases: from protein to cell pathology | Q37075786 | ||
| Knockdown of m-calpain increases survival of primary hippocampal neurons following NMDA excitotoxicity | Q37177242 | ||
| Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model | Q37341124 | ||
| Quantitative Comparison of Dense-Core Amyloid Plaque Accumulation in Amyloid-β Protein Precursor Transgenic Mice | Q37610732 | ||
| The interplay between mitochondrial dynamics and mitophagy | Q37815475 | ||
| Cytochrome c oxidase and its role in neurodegeneration and neuroprotection | Q38021402 | ||
| Are oxidative stress and mitochondrial dysfunction the key players in the neurodegenerative diseases? | Q38027902 | ||
| Genetic mouse models of brain ageing and Alzheimer's disease | Q38173230 | ||
| Experimental Models of Inherited PrP Prion Diseases | Q39092626 | ||
| Effect of conjugated linoleic acid, μ-calpain inhibitor, on pathogenesis of Alzheimer's disease | Q39224973 | ||
| Cyclin dependent kinase 5: A novel avenue for Alzheimer's disease | Q39319073 | ||
| Mitochondrial Respiration Is Impaired during Late-Stage Hamster Prion Infection | Q40141938 | ||
| Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression | Q40301497 | ||
| Role of hippocampal signaling pathways in long-term memory formation of a nonassociative learning task in the rat | Q40416447 | ||
| Development and therapeutic potential of calpain inhibitors | Q41188037 | ||
| Targeting Cdk5 activity in neuronal degeneration and regeneration | Q41720010 | ||
| Incorporation and metabolism of punicic acid in healthy young humans. | Q43276731 | ||
| Differential neurobehavioral deficits induced by apomorphine and its oxidation product, 8-oxo-apomorphine-semiquinone, in rats. | Q44014663 | ||
| Incorporation of conjugated linoleic acid into brain lipids is not necessary for conjugated linoleic acid-induced reductions in feed intake or body fat in mice | Q44980817 | ||
| Calpain inhibitor inhibits p35-p25-Cdk5 activation, decreases tau hyperphosphorylation, and improves neurological function after spinal cord hemisection in rats | Q45268625 | ||
| Punicic acid from Trichosanthes kirilowii seed oil is rapidly metabolized to conjugated linoleic acid in rats. | Q46002371 | ||
| Role of cyclin-dependent kinase 5 in the neurodegenerative process triggered by amyloid-Beta and prion peptides: implications for Alzheimer's disease and prion-related encephalopathies. | Q46927043 | ||
| Differential effects of chronic stress in young-adult and old female mice: cognitive-behavioral manifestations and neurobiological correlates. | Q47562648 | ||
| Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease | Q47714762 | ||
| Calcium dysregulation and Cdk5-ATM pathway involved in a mouse model of fragile X-associated tremor/ataxia syndrome | Q47739915 | ||
| Aged Tg2576 mice are impaired on social memory and open field habituation tests | Q48317805 | ||
| Evidence for early cognitive impairment related to frontal cortex in the 5XFAD mouse model of Alzheimer's disease. | Q48346702 | ||
| Assessment of spatial memory using the T maze | Q48347939 | ||
| Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. | Q48404445 | ||
| On the delay-dependent involvement of the hippocampus in object recognition memory | Q48542116 | ||
| Phos-tau peptide immunization of amyloid-tg-mice reduced non-mutant phos-tau pathology, improved cognition and reduced amyloid plaques | Q50060997 | ||
| Continues administration of Nano-PSO significantly increased survival of genetic CJD mice. | Q50494246 | ||
| Prions, prionoids and protein misfolding disorders. | Q54224345 | ||
| Punicic acid was metabolised and incorporated in the form of conjugated linoleic acid in different rat tissues | Q57453356 | ||
| Dissociable cognitive impairments in two strains of transgenic Alzheimer's disease mice revealed by a battery of object-based tests | Q60912224 | ||
| Effects of Novel Calpain Inhibitors in Transgenic Animal Model of Parkinson's disease/dementia with Lewy bodies | Q60932604 | ||
| Prion and Prion-Like Protein Strains: Deciphering the Molecular Basis of Heterogeneity in Neurodegeneration | Q64096411 | ||
| The Prion Diseases | Q85180476 | ||
| Pomegranate seed oil nanoemulsions for the prevention and treatment of neurodegenerative diseases: the case of genetic CJD | Q87620152 | ||
| Resident brain neural precursor cells develop age-dependent loss of therapeutic functions in Alzheimer's mice | Q91387633 | ||
| Comparison of β-Amyloid Plaque Labeling Methods: Antibody Staining, Gallyas Silver Staining, and Thioflavin-S Staining | Q91853789 | ||
| Mitochondrial dysfunction in preclinical genetic prion disease: A target for preventive treatment? | Q93038367 | ||
| P2507 | corrigendum / erratum | Author Correction: Brain targeting of 9c,11t-Conjugated Linoleic Acid, a natural calpain inhibitor, preserves memory and reduces Aβ and P25 accumulation in 5XFAD mice | Q92890179 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P304 | page(s) | 18437 | |
| P577 | publication date | 2019-12-05 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Brain targeting of 9c,11t-Conjugated Linoleic Acid, a natural calpain inhibitor, preserves memory and reduces Aβ and P25 accumulation in 5XFAD mice | |
| P478 | volume | 9 |
Search more.